UKCapital Intelligence Plans
← Funding directory

Dated funding evidence

Apollo Therapeutics

Series C (second close) · $33.5M · 2024-01-02

Reported round$33.5MSeries C (second close)
Disclosure date
2024-01-02
Reported currency
USD
Companies House
13393274
Evidence sources
1

Company

Apollo TherapeuticsCH 13393274
2024-01-02Series C (second close)$33.5M

Resolved investor records

M&G plcInvestorRock Springs CapitalInvestortwo large US public pension plansInvestor

Investor links inherit this round’s named source and date. Resolved links use an exact canonical investor name; unresolved names remain unlinked.

SourceVC research snapshot; Live Chris T D1Date2024-01-02Matchfunding_id joined to resolved canonical companyStatepublished

Record fields

What the source states

Amounts, currency, stage and investor names are preserved as reported. No FX conversion, valuation inference or current-holding claim is added.

Round ID
FR-00024
Stage
Series C (second close)
Round name
Series C (second close)
Amount
$33.5M
Lead investors
Not stated
Other investors
M&G plc, Rock Springs Capital, two large US public pension plans
Source layers
VC research snapshot, Live Chris T D1
Snapshot
2026-08-25

Named evidence

Source trail

This page is published only when the record has a resolved company, disclosure date, round stage and at least one retained source URL.